Latest News
Penumbra, Inc.
- Penumbra, Inc. Estimates – NYSE:PEN
- Penumbra receives US FDA clearance for Lightning CAVT technology for the treatment of DVT
- Penumbra Says FDA Clears CAVT Technology for Deep Vein Thrombosis
- FDA clears Penumbra’s CAVT technology for DVT treatment
- FDA clears Penumbra’s CAVT technology for DVT treatment By Investing.com
- Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
- Boston Scientific/Penumbra: Divestiture Buyer Sought for Embolization Coils Business to Address FTC Concerns
- Form 4 Penumbra Inc: Shruthi Narayan (President) For: 15 October By Investing.com
- Penumbra Mezcal Launches –
- Could STORM-PE Data Change Penumbra (NASDAQ:PEN) Story?
- Can Penumbra (PEN) Justify Its Valuation As STORM PE Data Strengthens Its Recovery Story?
- The Mechanical Penumbra in Intracerebral Hemorrhage
Headlines from the last 30 days, linking to the original publishers. See all market news →